The Nobel Assembly at Karolinska Institutet has decided to award the 2011 Nobel Prize in Physiology or Medicine to three immunologists, Bruce Beutler, Jules A. Hoffman, and Ralph M. Steinman. As stated in the press release from the Nobel Committee (http://www.nobelprize.org), these scientists are recognized for having revolutionized our understanding of the immune system by discovering key principles for its activation. Immunologists had long been searching for the gatekeepers of the immune response by which man and other animals defend themselves against attack by microorganisms. Jules A. Hoffmann and Bruce Beutler discovered key receptor proteins, Toll/Toll-like receptors, which can recognize microorganisms and activate innate immune responses. Ralph Steinman discovered dendritic cells (DC) and their unique capacity to activate and regulate T lymphocytes, paving the way for activation of adaptive immune responses. Jules Hoffmann made his pioneering discovery in 1996, when he and his co-workers investigated how fruit flies combat infections [1]. They had access to flies with mutations in several different genes including Toll, a gene previously found to be involved in embryonal development. When Hoffmann infected Toll mutant fruit flies with bacteria or fungi, he discovered that the Toll mutants infected with fungi died because they could not mount an effective immune response. Bruce Beutler was searching for a receptor that could bind the bacterial product, lipopolysaccharide (LPS), which can cause septic shock, a life-threatening condition that involves overstimulation of the immune system. In 1998, Beutler and his colleagues discovered that mice that were resistant to LPS had a mutation in a gene that was similar to the Toll gene of the fruit fly [2]. This Toll-like receptor (TLR) turned out to be the elusive LPS receptor. These findings showed that mammals and fruit flies use similar molecules to activate innate immunity when encountering pathogenic microorganisms. As concluded by the Nobel Committee (http://www.nobelprize.org), the discoveries of Hoffmann and Beutler triggered an explosion of research in innate immunity. Around a dozen different TLRs have now been identified in humans and mice, and several other receptor families with similar functions have been identified. Each one of them recognizes certain types of molecules common in microorganisms. Individuals with certain mutations in these receptors carry an increased risk of infections. Ralph Steinman discovered, in 1973, a new type of cell that he called the dendritic cell (DC) [3]. He speculated that DC could be important in the immune system and went on to test whether antigens in the presence of DC could activate T lymphocytes, key cells in adaptive immunity [4]. In cell culture experiments, he showed that the presence of DC resulted in vivid responses of T cells to antigens. Findings by Steinman were initially met with some scepticism but subsequent work by Steinman demonstrated that DC had an absolutely unique capacity to activate T cells. Further studies by Steinman [5] and by other scientists went on to address how DCs decide whether or not they should activate T lymphocytes when encountering self or foreign ‘antigens’. Signals arising from the innate immune response via TLR, sensed by DC, were shown to control T cell activation. This makes it possible for T lymphocytes to react towards pathogenic microorganisms while avoiding an attack on the body’s own endogenous molecules. The discoveries that are awarded the 2011 Nobel Prize have provided novel insights into the activation and regulation of the immune system. They have made possible the development of new methods for preventing and treating disease, for instance with improved vaccines against infections and in attempts to stimulate the immune system to attack tumours. These discoveries also help us understand why the immune system can attack our own tissues, thus providing clues for novel treatment of inflammatory diseases.
Read full abstract